Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Farabee

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Psychoactive Drugs|November 9, 2002
Methamphetamine use and HIV risk among substance-abusing offenders in CaliforniaDavid Farabee, Michael Prendergast, Jerome Cartier
Journal of Consulting and Clinical Psychology|April 18, 2003
Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventionsNena Messina, David Farabee, Richard Rawson
Journal of Psychoactive Drugs|December 22, 2011
A preliminary examination of offender needs assessment: are all those questions really necessary?David Farabee, Sheldon Zhang, Joy Yang
Journal of the American Academy of Child and Adolescent Psychiatry|December 8, 2018
Mobile Health (mHealth): Building the Case for Adapting Emerging Technologies for Justice-Involved YouthEraka Bath, Marina Tolou-Shams, David Farabee
Journal of Interpersonal Violence|February 28, 2006
Methamphetamine use, self-reported violent crime, and recidivism among offenders in California who abuse substancesJerome Cartier, David Farabee, Michael L Prendergast
Psychiatry Research|May 18, 2019
The impact of perceived stigma on psychiatric care and outcomes for correctional mental health patientsDavid Farabee, Elizabeth Hall, Arsal Zaheer, et al.
Psychiatric Research and Clinical Practice|September 15, 2023
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-CliniciansAngela Di Paola, David Farabee, Sandra A Springer
Substance Abuse and Rehabilitation|February 29, 2020
An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]Walter Ling, David Farabee, Vijay R Nadipelli, et al.
Substance Abuse and Rehabilitation|April 13, 2013
The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addictionWalter Ling, David Farabee, Dagmar Liepa, et al.
Journal of Substance Abuse Treatment|August 20, 2020
A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorderDavid Farabee, Timothy Condon, Kevin A Hallgren, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Psychoactive Drugs|November 9, 2002
Methamphetamine use and HIV risk among substance-abusing offenders in CaliforniaDavid Farabee, Michael Prendergast, Jerome Cartier
Journal of Consulting and Clinical Psychology|April 18, 2003
Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventionsNena Messina, David Farabee, Richard Rawson
Journal of Psychoactive Drugs|December 22, 2011
A preliminary examination of offender needs assessment: are all those questions really necessary?David Farabee, Sheldon Zhang, Joy Yang
Journal of the American Academy of Child and Adolescent Psychiatry|December 8, 2018
Mobile Health (mHealth): Building the Case for Adapting Emerging Technologies for Justice-Involved YouthEraka Bath, Marina Tolou-Shams, David Farabee
Journal of Interpersonal Violence|February 28, 2006
Methamphetamine use, self-reported violent crime, and recidivism among offenders in California who abuse substancesJerome Cartier, David Farabee, Michael L Prendergast
Psychiatry Research|May 18, 2019
The impact of perceived stigma on psychiatric care and outcomes for correctional mental health patientsDavid Farabee, Elizabeth Hall, Arsal Zaheer, et al.
Psychiatric Research and Clinical Practice|September 15, 2023
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-CliniciansAngela Di Paola, David Farabee, Sandra A Springer
Substance Abuse and Rehabilitation|February 29, 2020
An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]Walter Ling, David Farabee, Vijay R Nadipelli, et al.
Substance Abuse and Rehabilitation|April 13, 2013
The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addictionWalter Ling, David Farabee, Dagmar Liepa, et al.
Journal of Substance Abuse Treatment|August 20, 2020
A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorderDavid Farabee, Timothy Condon, Kevin A Hallgren, et al.
Pageof 6